Melanie N. Frank

Freiburg, BW, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Quantifying bias due to missing data in quality of life surveys of advanced-stage cancer patients.

Quantifying bias due to missing data in quality of life surveys of advanced-stage cancer patients.

Journal: Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation

Published: December 11, 2023

PERFORM: a non-interventional study assessing the patients' treatment starting with 1L palbociclib in HR+/HER2- ABC.

PERFORM: a non-interventional study assessing the patients' treatment starting with 1L palbociclib in HR+/HER2- ABC.

Journal: Future oncology (London, England)

Published: November 25, 2022

Effectiveness, safety and quality of life of trifluridine/tipiracil in pretreated patients with metastatic colorectal cancer: Real-world data from the noninterventional TACTIC study in Germany.

Effectiveness, safety and quality of life of trifluridine/tipiracil in pretreated patients with metastatic colorectal cancer: Real-world data from the noninterventional TACTIC study in Germany.

Journal: International journal of cancer

Published: November 25, 2022

Real-world patient-reported outcomes of breast cancer or prostate cancer patients receiving antiresorptive therapy for bone metastases: Final results of the PROBone registry study.

Real-world patient-reported outcomes of breast cancer or prostate cancer patients receiving antiresorptive therapy for bone metastases: Final results of the PROBone registry study.

Journal: Journal of bone oncology

Published: October 06, 2021

Use of vitamin and mineral supplements among adolescents living in Germany-Results from EsKiMo II.

Use of vitamin and mineral supplements among adolescents living in Germany-Results from EsKiMo II.

Journal: Nutrients

Published: April 12, 2019

SWITCH II: Phase III randomized, sequential, open-label study to evaluate the efficacy and safety of sorafenib-pazopanib versus pazopanib-sorafenib in the treatment of advanced or metastatic renal cell carcinoma (AUO AN 33/11).

SWITCH II: Phase III randomized, sequential, open-label study to evaluate the efficacy and safety of sorafenib-pazopanib versus pazopanib-sorafenib in the treatment of advanced or metastatic renal cell carcinoma (AUO AN 33/11).

Journal: European journal of cancer (Oxford, England : 1990)

Published: June 17, 2018

EsKiMo II - the Eating study as a KiGGS Module in KiGGS Wave 2.

EsKiMo II - the Eating study as a KiGGS Module in KiGGS Wave 2.

Journal: Journal of health monitoring

Published: September 27, 2017

Routine treatment and outcome of breast cancer in younger versus elderly patients: results from the SENORA project of the prospective German TMK cohort study.

Routine treatment and outcome of breast cancer in younger versus elderly patients: results from the SENORA project of the prospective German TMK cohort study.

Journal: Breast cancer research and treatment

Published: July 25, 2017

Adjuvant chemotherapeutic treatment of 1650 patients with early breast cancer in routine care in Germany: data from the prospective TMK cohort study.

Adjuvant chemotherapeutic treatment of 1650 patients with early breast cancer in routine care in Germany: data from the prospective TMK cohort study.

Journal: Breast cancer (Tokyo, Japan)

Published: June 27, 2017

Shunt age-related complications in adult patients with suspected shunt dysfunction. A recommended diagnostic workup.

Shunt age-related complications in adult patients with suspected shunt dysfunction. A recommended diagnostic workup.

Journal: Acta neurochirurgica

Published: February 01, 2017

Antianemic Treatment of Cancer Patients in German Routine Practice: Data from a Prospective Cohort Study-The Tumor Anemia Registry.

Antianemic Treatment of Cancer Patients in German Routine Practice: Data from a Prospective Cohort Study-The Tumor Anemia Registry.

Journal: Anemia

Published: October 01, 2015

Oxaliplatin-based first-line chemotherapy is associated with improved overall survival compared to first-line treatment with irinotecan-based chemotherapy in patients with metastatic colorectal cancer - Results from a prospective cohort study.

Oxaliplatin-based first-line chemotherapy is associated with improved overall survival compared to first-line treatment with irinotecan-based chemotherapy in patients with metastatic colorectal cancer - Results from a prospective cohort study.

Journal: Clinical epidemiology

Published: May 07, 2015

Showing 1-12 of 12

Last Updated: 09/26/2026